KOLIBER BIOSCIENCES INC.
San Diego, CA · Biotech · Private
Deep learning framework using novel neural network architectures and data encoding to predict peptides with anti-inflammatory activity for drug discovery
- Grants
- $1.0M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Genetic toolkit for genome editing of the Lactobacillus genus. | $224,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Genetic toolkit for genome editing of the Lactobacillus genus. | $224,999 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Artificial Intelligence Platform for Peptide Drug Discovery | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Artificial intelligence based platform for peptide lead optimization. | $350,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2758 | LINNAEUS BIOSCIENCE, INC. | — | — |
| 2759 | Lassen Therapeutics | — | — |
| 2760 | ORGANIX, INC. | — | — |
| 2761 | KOLIBER BIOSCIENCES INC. | — | — |
| 2762 | VIRTUS THERAPEUTICS CORPORATION | — | — |
| 2763 | SPECIFICA, INC. | — | — |
| 2764 | SAFI BIOTHERAPEUTICS INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Peptides With Cytokine-releasing Activity And Methods For Characterizing Cytokine-releasing Profiles Of Peptidesapplication
- Peptides With Cytokine-releasing Activity And Methods For Characterizing Cytokine-releasing Profiles Of Peptidesapplication
- Peptides With Cytokine-releasing Activity And Methods For Characterizing Cytokine-releasing Profiles Of Peptidesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.